Pre-Treatment Testing with Biologics Falls Short US commercial insurance claim analysis of lab screening and monitoring practices in CISD patients shows that < 60% received the reco pretreatment testing when starting systemic immunomodulatory treatment. https://t.co/WdI3xfMyng https://t.co/xxKVkag60o